(Q22306219)

PubMed

PubMed publication ID

15798098

10 April 2023

Songqing Na

series ordinal

2

author given names

Songqing

author last names

Na

1 reference

PubMed

PubMed publication ID

15798098

10 April 2023

Radhakrishnan Rathnachalam

series ordinal

3

author given names

Radhakrishnan

author last names

Rathnachalam

1 reference

PubMed

PubMed publication ID

15798098

Inhibition of Th1 development and treatment of chronic-relapsing experimental allergic encephalomyelitis by a non-hypercalcemic analogue of 1,25-dihydroxyvitamin D(3)

10 April 2023

language of work or name

English

0 references

publication date

August 2005

0 references

published in

Endocrine Reviews

0 references

volume

26

0 references

issue

5

0 references

page(s)

662-687

0 references

cites work

1 reference

https://api.crossref.org/works/10.1210%2FER.2004-0002

7 January 2021

The effect of 1-hydroxyvitamin D3 for prolongation of leukemic transformation-free survival in myelodysplastic syndromes.

1 reference

https://api.crossref.org/works/10.1210%2FER.2004-0002

7 January 2021

Treatment of psoriatic arthritis with oral 1,25-dihydroxyvitamin D3: a pilot study

1 reference

https://api.crossref.org/works/10.1210%2FER.2004-0002

7 January 2021

Effects of a synthetic vitamin D analog, ED-71, on bone dynamics and strength in cancellous and cortical bone in prednisolone-treated rats

1 reference

https://api.crossref.org/works/10.1210%2FER.2004-0002

7 January 2021

Inhibition of prostate cancer growth by vitamin D: Regulation of target gene expression

1 reference

https://api.crossref.org/works/10.1210%2FER.2004-0002

7 January 2021

Vitamin D regulated keratinocyte differentiation: role of coactivators

1 reference

https://api.crossref.org/works/10.1210%2FER.2004-0002

7 January 2021

Tolerogenic dendritic cells induced by vitamin D receptor ligands enhance regulatory T cells inhibiting allograft rejection and autoimmune diseases.

1 reference

https://api.crossref.org/works/10.1210%2FER.2004-0002

7 January 2021

Evidence for tissue- and cell-type selective activation of the vitamin D receptor by Ro-26-9228, a noncalcemic analog of vitamin D3.

1 reference

https://api.crossref.org/works/10.1210%2FER.2004-0002

7 January 2021

A new active vitamin D analog, ED-71, causes increase in bone mass with preferential effects on bone in osteoporotic patients

1 reference

https://api.crossref.org/works/10.1210%2FER.2004-0002

7 January 2021

Vitamin D3 supports osteoclastogenesis via functional vitamin D response element of human RANKL gene promoter

1 reference

https://api.crossref.org/works/10.1210%2FER.2004-0002

7 January 2021

Role of intracellular-free calcium in the cornified envelope formation of keratinocytes: differences in the mode of action of extracellular calcium and 1,25 dihydroxyvitamin D3.

1 reference

https://api.crossref.org/works/10.1210%2FER.2004-0002

7 January 2021

Novel nonsecosteroidal vitamin D receptor modulator inhibits the growth of LNCaP xenograft tumors in athymic mice without increased serum calcium

1 reference

https://api.crossref.org/works/10.1210%2FER.2004-0002

7 January 2021

IGF-binding proteins in human prostate tumor cells: expression and regulation by 1,25-dihydroxyvitamin D3.

1 reference

https://api.crossref.org/works/10.1210%2FER.2004-0002

7 January 2021

1,25 dihydroxyvitamin D3 enhances the calcium response of keratinocytes

1 reference

https://api.crossref.org/works/10.1210%2FER.2004-0002

7 January 2021

Vitamin D analogues in insulin-dependent diabetes mellitus and other autoimmune diseases: a therapeutic perspective

1 reference

https://api.crossref.org/works/10.1210%2FER.2004-0002

7 January 2021

Increased intracellular Th1 cytokines in scid mice with inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1210%2FER.2004-0002

7 January 2021

Expression of 1,25-dihydroxyvitamin D(3) receptor in the immune system

1 reference

https://api.crossref.org/works/10.1210%2FER.2004-0002

7 January 2021

The interaction of the vitamin D receptor with nuclear receptor corepressors and coactivators

1 reference

https://api.crossref.org/works/10.1210%2FER.2004-0002

7 January 2021

ZK 156718, a low calcemic, antiproliferative, and prodifferentiating vitamin D analog

1 reference

https://api.crossref.org/works/10.1210%2FER.2004-0002

7 January 2021

Vitamin D(3) augments osteoclastogenesis via vitamin D-responsive element of mouse RANKL gene promoter

1 reference

https://api.crossref.org/works/10.1210%2FER.2004-0002

7 January 2021

Satisfying hydrogen bonding potential in proteins

1 reference

https://api.crossref.org/works/10.1210%2FER.2004-0002

7 January 2021

Prevention of autoimmune diabetes in NOD mice by 1,25 dihydroxyvitamin D3

1 reference

https://api.crossref.org/works/10.1210%2FER.2004-0002

7 January 2021

1 alpha,25-Dihydroxyvitamin D3 inhibits the invasive potential of human breast cancer cells in vitro

1 reference

https://api.crossref.org/works/10.1210%2FER.2004-0002

7 January 2021

1,25-(OH)2-vitamin D3 and calcipotriol induce IL-10 receptor gene expression in human epidermal cells

1 reference

https://api.crossref.org/works/10.1210%2FER.2004-0002

7 January 2021

Vitamin D deficiency in early life accelerates Type 1 diabetes in non-obese diabetic mice

1 reference

https://api.crossref.org/works/10.1210%2FER.2004-0002

7 January 2021

Efficacy of alphacalcidol and calcitriol in primary and corticosteroid-induced osteoporosis: a meta-analysis of their effects on bone mineral density and fracture rate

1 reference

https://api.crossref.org/works/10.1210%2FER.2004-0002

7 January 2021

Bone mass and markers of bone and calcium metabolism in postmenopausal women treated with 1,25-dihydroxyvitamin D (Calcitriol) for four years

1 reference

https://api.crossref.org/works/10.1210%2FER.2004-0002

7 January 2021

Role of alfacalcidiol on bone quality and immunomodulation in autoimmune disease and organ transplantation

1 reference

https://api.crossref.org/works/10.1210%2FER.2004-0002

7 January 2021

Vitamin D therapy of osteoporosis: plain vitamin D therapy versus active vitamin D analog (D-hormone) therapy.

1 reference

https://api.crossref.org/works/10.1210%2FER.2004-0002

7 January 2021

The advantage of alfacalcidol over vitamin D in the treatment of osteoporosis

1 reference

https://api.crossref.org/works/10.1210%2FER.2004-0002

7 January 2021

Alfacalcidol and calcitriol in the prevention of bone loss after organ transplantation

1 reference

https://api.crossref.org/works/10.1210%2FER.2004-0002

7 January 2021

The vitamin D3 analog, ILX-23-7553, enhances the response to adriamycin and irradiation in MCF-7 breast tumor cells

1 reference

https://api.crossref.org/works/10.1210%2FER.2004-0002

7 January 2021

Effect of the vitamin D3 analog ILX 23-7553 on apoptosis and sensitivity to fractionated radiation in breast tumor cells and normal human fibroblasts

1 reference

https://api.crossref.org/works/10.1210%2FER.2004-0002

7 January 2021

Treatment of experimental autoimmune encephalomyelitis in rat by 1,25-dihydroxyvitamin D3 leads to early effects within the central nervous system

1 reference

https://api.crossref.org/works/10.1210%2FER.2004-0002

7 January 2021

1 alpha-hydroxyvitamin D3 inhibits type II collagen-induced arthritis in rats

1 reference

https://api.crossref.org/works/10.1210%2FER.2004-0002

7 January 2021

Action of 1,25-dihydroxyvitamin D3 on calcium balance and bone turnover and its effect on vertebral fracture rate

1 reference

https://api.crossref.org/works/10.1210%2FER.2004-0002

7 January 2021

Geographic variation in breast cancer mortality in the United States: a hypothesis involving exposure to solar radiation

1 reference

https://api.crossref.org/works/10.1210%2FER.2004-0002

7 January 2021

Interleukin-10-deficient mice develop chronic enterocolitis

1 reference

https://api.crossref.org/works/10.1210%2FER.2004-0002

7 January 2021

Interactions of 1,25-dihydroxyvitamin D3 and the immune system

1 reference

https://api.crossref.org/works/10.1210%2FER.2004-0002

7 January 2021

1,25-dihydroxyvitamin D3 receptors in normal and malignant human colorectal tissues

1 reference

https://api.crossref.org/works/10.1210%2FER.2004-0002

7 January 2021

Two novel vitamin D analogues, KH 1060 and CB 966, prolong skin allograft survival in mice

1 reference

https://api.crossref.org/works/10.1210%2FER.2004-0002

7 January 2021

Liganded VDR induces CYP3A4 in small intestinal and colon cancer cells via DR3 and ER6 vitamin D responsive elements.

1 reference

https://api.crossref.org/works/10.1210%2FER.2004-0002

7 January 2021

Suppressive effect of 1,25-dihydroxyvitamin D3 and its analogues EB 1089 and KH 1060 on T lymphocyte proliferation in active ulcerative colitis

1 reference

https://api.crossref.org/works/10.1210%2FER.2004-0002

7 January 2021

Immunomodulatory properties of a 1,25(OH)(2) vitamin D(3) analog combined with IFNbeta in an animal model of syngeneic islet transplantation

1 reference

https://api.crossref.org/works/10.1210%2FER.2004-0002

7 January 2021

A combination of KH1060, a vitamin D(3) analogue, and cyclosporin prevents early graft failure and prolongs graft survival of xenogeneic islets in nonobese diabetic mice

1 reference

https://api.crossref.org/works/10.1210%2FER.2004-0002

7 January 2021

Prevention of Diabetes Recurrence After Syngeneic Islet Transplantation in NOD Mice by Analogues of 1,25(OH)2D3 in Combination With Cyclosporin A: Mechanism of Action Involves an Immune Shift From TH1 to TH2

1 reference

https://api.crossref.org/works/10.1210%2FER.2004-0002

7 January 2021

Immunomodulatory effects of vitamin D analog KH1060 on an experimental skin transplantation model

1 reference

https://api.crossref.org/works/10.1210%2FER.2004-0002

7 January 2021

Vitamin d inhibition of prostate adenocarcinoma growth and metastasis in the dunning rat prostate model system

1 reference

https://api.crossref.org/works/10.1210%2FER.2004-0002

7 January 2021

Cell death mediators in autoimmune diabetes--no shortage of suspects

1 reference

https://api.crossref.org/works/10.1210%2FER.2004-0002

7 January 2021

A novel transcription factor, T-bet, directs Th1 lineage commitment

1 reference

https://api.crossref.org/works/10.1210%2FER.2004-0002

7 January 2021

https://api.crossref.org/works/10.1210%2FER.2004-0002

1 reference

7 January 2021

Myeloid and monocytoid leukemia cells have different sensitivity to differentiation-inducing activity of deoxyadenosine analogs.

1 reference

https://api.crossref.org/works/10.1210%2FER.2004-0002

7 January 2021

Rag-1-dependent cells are necessary for 1,25-dihydroxyvitamin D(3) prevention of experimental autoimmune encephalomyelitis

1 reference

https://api.crossref.org/works/10.1210%2FER.2004-0002

7 January 2021

1,25-dihydroxyvitamin D3 treatment decreases macrophage accumulation in the CNS of mice with experimental autoimmune encephalomyelitis

1 reference

https://api.crossref.org/works/10.1210%2FER.2004-0002

7 January 2021

1,25-Dihydroxyvitamin D(3) inhibits dendritic cell differentiation and maturation in vitro

1 reference

https://api.crossref.org/works/10.1210%2FER.2004-0002

7 January 2021

Vitamin D-mediated growth inhibition of an androgen-ablated LNCaP cell line model of human prostate cancer

1 reference

https://api.crossref.org/works/10.1210%2FER.2004-0002

7 January 2021

Des (1-3) IGF-I-stimulated growth of human stromal BPH cells is inhibited by a vitamin D3 analogue

1 reference

https://api.crossref.org/works/10.1210%2FER.2004-0002

7 January 2021

Characterization of the activation function-2 domain of the human 1,25-dihydroxyvitamin D3 receptor

1 reference

https://api.crossref.org/works/10.1210%2FER.2004-0002

7 January 2021

Action of 1,25(OH)2D3 on the cell cycle genes, cyclin D1, p21 and p27 in MCF-7 cells

1 reference

https://api.crossref.org/works/10.1210%2FER.2004-0002

7 January 2021

Leukemia cell differentiation: cellular and molecular interactions of retinoids and vitamin D

1 reference

https://api.crossref.org/works/10.1210%2FER.2004-0002

7 January 2021

1 reference

https://api.crossref.org/works/10.1210%2FER.2004-0002

7 January 2021

Efficacy of Vitamin D compounds to modulate estrogen receptor negative breast cancer growth and invasion.

1 reference

https://api.crossref.org/works/10.1210%2FER.2004-0002

7 January 2021

Localization of 1,25-dihydroxyvitamin D3 receptor (VDR) expression in human prostate

1 reference

https://api.crossref.org/works/10.1210%2FER.2004-0002

7 January 2021

In vivo function of VDR in gene expression-VDR knock-out mice

1 reference

https://api.crossref.org/works/10.1210%2FER.2004-0002

7 January 2021

Syntheses and preventive effects of analogues related to 1alpha,25-dihydroxy-2beta-(3-hydroxypropoxy)vitamin D3 (ED-71) on bone mineral loss in ovariectomized rats

1 reference

https://api.crossref.org/works/10.1210%2FER.2004-0002

7 January 2021

Nuclear receptor coregulators: multiple modes of modification

1 reference

https://api.crossref.org/works/10.1210%2FER.2004-0002

7 January 2021

Novel nonsecosteroidal vitamin D mimics exert VDR-modulating activities with less calcium mobilization than 1,25-dihydroxyvitamin D3

1 reference

https://api.crossref.org/works/10.1210%2FER.2004-0002

7 January 2021

The crystal structure of the nuclear receptor for vitamin D bound to its natural ligand

1 reference

https://api.crossref.org/works/10.1210%2FER.2004-0002

7 January 2021

Novel approaches for the treatment of psoriasis

1 reference

https://api.crossref.org/works/10.1210%2FER.2004-0002

7 January 2021

Dendritic cells as a tool to induce anergic and regulatory T cells

1 reference

https://api.crossref.org/works/10.1210%2FER.2004-0002

7 January 2021

The coming of age of 1,25-dihydroxyvitamin D(3) analogs as immunomodulatory agents

1 reference

https://api.crossref.org/works/10.1210%2FER.2004-0002

7 January 2021

Immunomodulatory effects of vitamin D receptor ligands in autoimmune diseases

1 reference

https://api.crossref.org/works/10.1210%2FER.2004-0002

7 January 2021

ED-71, a vitamin D analog, is a more potent inhibitor of bone resorption than alfacalcidol in an estrogen-deficient rat model of osteoporosis

1 reference

https://api.crossref.org/works/10.1210%2FER.2004-0002

7 January 2021

The vitamin D3 analog EB 1089 enhances the antiproliferative and apoptotic effects of adriamycin in MCF-7 breast tumor cells

1 reference

https://api.crossref.org/works/10.1210%2FER.2004-0002

7 January 2021

Prostate cancer risk and prediagnostic serum 25-hydroxyvitamin D levels (Finland)

1 reference

https://api.crossref.org/works/10.1210%2FER.2004-0002

7 January 2021

Analysis of vitamin D-receptor (VDR) and retinoid X-receptor alpha in breast cancer

1 reference

https://api.crossref.org/works/10.1210%2FER.2004-0002

7 January 2021

Dendritic cells and the control of immunity

1 reference

https://api.crossref.org/works/10.1210%2FER.2004-0002

7 January 2021

Skin abnormalities generated by temporally controlled RXRalpha mutations in mouse epidermis

1 reference

https://api.crossref.org/works/10.1210%2FER.2004-0002

7 January 2021

Interaction of thyroid-hormone receptor with a conserved transcriptional mediator

1 reference

https://api.crossref.org/works/10.1210%2FER.2004-0002

7 January 2021

Crystal structure of the ligand-binding domain of the human nuclear receptor RXR-alpha

1 reference

https://api.crossref.org/works/10.1210%2FER.2004-0002

7 January 2021

Crystal structure of the RAR-gamma ligand-binding domain bound to all-trans retinoic acid

1 reference

https://api.crossref.org/works/10.1210%2FER.2004-0002

7 January 2021

The transcriptional co-activator p/CIP binds CBP and mediates nuclear-receptor function

1 reference

https://api.crossref.org/works/10.1210%2FER.2004-0002

7 January 2021

Quantitative mapping of amplicon structure by array CGH identifies CYP24 as a candidate oncogene

1 reference

https://api.crossref.org/works/10.1210%2FER.2004-0002

7 January 2021

The NOD mouse model of type 1 diabetes: as good as it gets?

1 reference

https://api.crossref.org/works/10.1210%2FER.2004-0002

7 January 2021

Mice lacking the vitamin D receptor exhibit impaired bone formation, uterine hypoplasia and growth retardation after weaning

1 reference

https://api.crossref.org/works/10.1210%2FER.2004-0002

7 January 2021

A canonical structure for the ligand-binding domain of nuclear receptors

1 reference

https://api.crossref.org/works/10.1210%2FER.2004-0002

7 January 2021

A phase II study of the vitamin D analogue Seocalcitol in patients with inoperable hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1210%2FER.2004-0002

7 January 2021

Combination of 22-oxa-1,25-dihydroxyvitamin D(3), a vitamin D(3) derivative, with vitamin K(2) (VK2) synergistically enhances cell differentiation but suppresses VK2-inducing apoptosis in HL-60 cells

1 reference

https://api.crossref.org/works/10.1210%2FER.2004-0002

7 January 2021

Modulation of cell cycle control by vitamin D3 and its analogue, EB1089, in human breast cancer cells

1 reference

https://api.crossref.org/works/10.1210%2FER.2004-0002

7 January 2021

Calcipotriene-induced improvement in psoriasis is associated with reduced interleukin-8 and increased interleukin-10 levels within lesions

1 reference

https://api.crossref.org/works/10.1210%2FER.2004-0002

7 January 2021

Topical maxacalcitol for the treatment of psoriasis vulgaris: a placebo-controlled, double-blind, dose-finding study with active comparator

1 reference

https://api.crossref.org/works/10.1210%2FER.2004-0002

7 January 2021

Long-term efficacy and safety of tacalcitol ointment in patients with chronic plaque psoriasis

1 reference

https://api.crossref.org/works/10.1210%2FER.2004-0002

7 January 2021

Molecular basis of the alteration in skin collagen metabolism in response to in vivo dexamethasone treatment: effects on the synthesis of collagen type I and III, collagenase, and tissue inhibitors of metalloproteinases

1 reference

https://api.crossref.org/works/10.1210%2FER.2004-0002

7 January 2021

Vitamin D treatment in myelodysplastic syndromes

1 reference

https://api.crossref.org/works/10.1210%2FER.2004-0002

7 January 2021

Differentiation therapy of myelodysplastic syndromes: fact or fiction?

1 reference

https://api.crossref.org/works/10.1210%2FER.2004-0002

7 January 2021

A vitamin D analogue (MC 1288) has immunomodulatory properties and suppresses collagen-induced arthritis (CIA) without causing hypercalcaemia

1 reference

https://api.crossref.org/works/10.1210%2FER.2004-0002

7 January 2021

Treatment of autoimmune diabetes recurrence in non-obese diabetic mice by mouse interferon-beta in combination with an analogue of 1alpha,25-dihydroxyvitamin-D3.

1 reference

https://api.crossref.org/works/10.1210%2FER.2004-0002

7 January 2021

Functional and structural characterization of the insertion region in the ligand binding domain of the vitamin D nuclear receptor.

1 reference

https://api.crossref.org/works/10.1210%2FER.2004-0002

7 January 2021

Suppression of parathyroid hormone secretion in hemodialysis patients by a novel vitamin D analogue: 19-nor-1,25-dihydroxyvitamin D2

1 reference

https://api.crossref.org/works/10.1210%2FER.2004-0002

7 January 2021

1 alpha,25-Dihydroxycholecalciferol reduces rejection and improves survival in rat liver allografts

1 reference

https://api.crossref.org/works/10.1210%2FER.2004-0002

7 January 2021

Treatment of postmenopausal osteoporosis with calcitriol or calcium

1 reference

https://api.crossref.org/works/10.1210%2FER.2004-0002

7 January 2021

Early onset of action and efficacy of a combination of calcipotriene and betamethasone dipropionate in the treatment of psoriasis

1 reference

https://api.crossref.org/works/10.1210%2FER.2004-0002

7 January 2021

Identification of an alternative ligand-binding pocket in the nuclear vitamin D receptor and its functional importance in 1alpha,25(OH)2-vitamin D3 signaling

1 reference

https://api.crossref.org/works/10.1210%2FER.2004-0002

7 January 2021

CD8(+) T cells are not necessary for 1 alpha,25-dihydroxyvitamin D(3) to suppress experimental autoimmune encephalomyelitis in mice

1 reference

https://api.crossref.org/works/10.1210%2FER.2004-0002

7 January 2021

Dendritic cell modulation by 1alpha,25 dihydroxyvitamin D3 and its analogs: a vitamin D receptor-dependent pathway that promotes a persistent state of immaturity in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1210%2FER.2004-0002

7 January 2021

Kaposi's sarcoma-associated herpesvirus-infected primary effusion lymphoma has a plasma cell gene expression profile

1 reference

https://api.crossref.org/works/10.1210%2FER.2004-0002

7 January 2021

A potent analog of 1alpha,25-dihydroxyvitamin D3 selectively induces bone formation

1 reference

https://api.crossref.org/works/10.1210%2FER.2004-0002

7 January 2021

Duodenal calcium absorption in vitamin D receptor-knockout mice: functional and molecular aspects

1 reference

https://api.crossref.org/works/10.1210%2FER.2004-0002

7 January 2021

Sequence elements in the human osteocalcin gene confer basal activation and inducible response to hormonal vitamin D3.

1 reference

https://api.crossref.org/works/10.1210%2FER.2004-0002

7 January 2021

Identification of a DNA sequence responsible for binding of the 1,25-dihydroxyvitamin D3 receptor and 1,25-dihydroxyvitamin D3 enhancement of mouse secreted phosphoprotein 1 (SPP-1 or osteopontin) gene expression

1 reference

https://api.crossref.org/works/10.1210%2FER.2004-0002

7 January 2021

1 alpha,25-dihydroxyvitamin D3 regulates the transcription of carbonic anhydrase II mRNA in avian myelomonocytes

1 reference

https://api.crossref.org/works/10.1210%2FER.2004-0002

7 January 2021

Sequences in the human parathyroid hormone gene that bind the 1,25-dihydroxyvitamin D3 receptor and mediate transcriptional repression in response to 1,25-dihydroxyvitamin D3

1 reference

https://api.crossref.org/works/10.1210%2FER.2004-0002

7 January 2021

Identification of a 1,25-dihydroxyvitamin D3-response element in the 5'-flanking region of the rat calbindin D-9k gene

1 reference

https://api.crossref.org/works/10.1210%2FER.2004-0002

7 January 2021

1,25-Dihydroxyvitamin D3 reversibly blocks the progression of relapsing encephalomyelitis, a model of multiple sclerosis

1 reference

https://api.crossref.org/works/10.1210%2FER.2004-0002

7 January 2021

RAC3, a steroid/nuclear receptor-associated coactivator that is related to SRC-1 and TIF2

1 reference

https://api.crossref.org/works/10.1210%2FER.2004-0002

7 January 2021

Targeted ablation of the vitamin D receptor: An animal model of vitamin D-dependent rickets type II with alopecia

1 reference

https://api.crossref.org/works/10.1210%2FER.2004-0002

7 January 2021

Multiple promoters direct the tissue-specific expression of novel N-terminal variant human vitamin D receptor gene transcripts

1 reference

https://api.crossref.org/works/10.1210%2FER.2004-0002

7 January 2021

SUG1, a putative transcriptional mediator and subunit of the PA700 proteasome regulatory complex, is a DNA helicase

1 reference

https://api.crossref.org/works/10.1210%2FER.2004-0002

7 January 2021

Granulocyte-macrophage colony-stimulating factor gene transcription is directly repressed by the vitamin D3 receptor. Implications for allosteric influences on nuclear receptor structure and function by a DNA element

1 reference

https://api.crossref.org/works/10.1210%2FER.2004-0002

7 January 2021

Identification of a Vitamin D Response Element in the Proximal Promoter of the Chicken Carbonic Anhydrase II Gene

1 reference

https://api.crossref.org/works/10.1210%2FER.2004-0002

7 January 2021

A Negative Vitamin D Response DNA Element in the Human Parathyroid Hormone-related Peptide Gene Binds to Vitamin D Receptor Along with Ku Antigen to Mediate Negative Gene Regulation by Vitamin D

1 reference

https://api.crossref.org/works/10.1210%2FER.2004-0002

7 January 2021

Sp1 and NF-Y synergistically mediate the effect of vitamin D(3) in the p27(Kip1) gene promoter that lacks vitamin D response elements

1 reference

https://api.crossref.org/works/10.1210%2FER.2004-0002

7 January 2021

The human transcription factor IID subunit human TATA-binding protein-associated factor 28 interacts in a ligand-reversible manner with the vitamin D(3) and thyroid hormone receptors

1 reference

https://api.crossref.org/works/10.1210%2FER.2004-0002

7 January 2021

A vitamin D receptor-Ser/Thr phosphatase-p70 S6 kinase complex and modulation of its enzymatic activities by the ligand

1 reference

https://api.crossref.org/works/10.1210%2FER.2004-0002

7 January 2021

Interactions of SKIP/NCoA-62, TFIIB, and retinoid X receptor with vitamin D receptor helix H10 residues

1 reference

https://api.crossref.org/works/10.1210%2FER.2004-0002

7 January 2021

Dimerization with retinoid X receptors promotes nuclear localization and subnuclear targeting of vitamin D receptors

1 reference

https://api.crossref.org/works/10.1210%2FER.2004-0002

7 January 2021

Ternary complexes and cooperative interplay between NCoA-62/Ski-interacting protein and steroid receptor coactivators in vitamin D receptor-mediated transcription

1 reference

https://api.crossref.org/works/10.1210%2FER.2004-0002

7 January 2021

2-Methylene-19-nor-(20S)-1,25-dihydroxyvitamin D3 potently stimulates gene-specific DNA binding of the vitamin D receptor in osteoblasts

1 reference

https://api.crossref.org/works/10.1210%2FER.2004-0002

7 January 2021

Physical and functional interaction between the vitamin D receptor and hairless corepressor, two proteins required for hair cycling

1 reference

https://api.crossref.org/works/10.1210%2FER.2004-0002

7 January 2021

Direct transcriptional regulation of RelB by 1alpha,25-dihydroxyvitamin D3 and its analogs: physiologic and therapeutic implications for dendritic cell function.

1 reference

https://api.crossref.org/works/10.1210%2FER.2004-0002

7 January 2021

Calcium homeostasis remains unaffected after 12 weeks' therapy with calcitriol 3 microg/g ointment; no correlation with extent of psoriasis

1 reference

https://api.crossref.org/works/10.1210%2FER.2004-0002

7 January 2021

Calcitriol shows greater persistence of treatment effect than betamethasone dipropionate in topical psoriasis therapy

1 reference

https://api.crossref.org/works/10.1210%2FER.2004-0002

7 January 2021

Immunocytology with microwave-fixed fibroblasts shows 1 alpha,25-dihydroxyvitamin D3-dependent rapid and estrogen-dependent slow reorganization of vitamin D receptors

1 reference

https://api.crossref.org/works/10.1210%2FER.2004-0002

7 January 2021

Vitamin D(3) promotes the differentiation of colon carcinoma cells by the induction of E-cadherin and the inhibition of beta-catenin signaling.

1 reference

https://api.crossref.org/works/10.1210%2FER.2004-0002

7 January 2021

1alpha,25-dihydroxyvitamin D(3)-induced myeloid cell differentiation is regulated by a vitamin D receptor-phosphatidylinositol 3-kinase signaling complex

1 reference

https://api.crossref.org/works/10.1210%2FER.2004-0002

7 January 2021

A protective role of 1,25-dihydroxyvitamin D3 in chemically induced rat colon carcinogenesis

1 reference

https://api.crossref.org/works/10.1210%2FER.2004-0002

7 January 2021

Characterization of a vitamin D receptor knockout mouse as a model of colorectal hyperproliferation and DNA damage

1 reference

https://api.crossref.org/works/10.1210%2FER.2004-0002

7 January 2021

Vitamin D(3) receptor ablation sensitizes skin to chemically induced tumorigenesis

1 reference

https://api.crossref.org/works/10.1210%2FER.2004-0002

7 January 2021

1,25-Dihydroxycholecalciferol Inhibits the Progression of Arthritis in Murine Models of Human Arthritis ,

1 reference

https://api.crossref.org/works/10.1210%2FER.2004-0002

7 January 2021

Transcriptional targets of the vitamin D3 receptor-mediating cell cycle arrest and differentiation

1 reference

https://api.crossref.org/works/10.1210%2FER.2004-0002

7 January 2021

1,25-Dihydroxycholecalciferol prevents and ameliorates symptoms of experimental murine inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1210%2FER.2004-0002

7 January 2021

Tributyrin, a stable and rapidly absorbed prodrug of butyric acid, enhances antiproliferative effects of dihydroxycholecalciferol in human colon cancer cells

1 reference

https://api.crossref.org/works/10.1210%2FER.2004-0002

7 January 2021

Antiproliferative action of vitamin D-related compounds and insulin-like growth factor-binding protein 5 accumulation

1 reference

https://api.crossref.org/works/10.1210%2FER.2004-0002

7 January 2021

LIGPLOT: a program to generate schematic diagrams of protein-ligand interactions

1 reference

https://api.crossref.org/works/10.1210%2FER.2004-0002

7 January 2021

Vitamin D: its role and uses in immunology

1 reference

https://api.crossref.org/works/10.1210%2FER.2004-0002

7 January 2021

Impaired insulin secretory capacity in mice lacking a functional vitamin D receptor

1 reference

https://api.crossref.org/works/10.1210%2FER.2004-0002

7 January 2021

Inhibition of c-myc in breast and ovarian carcinoma cells by 1,25-dihydroxyvitamin D3, retinoic acid and dexamethasone

1 reference

https://api.crossref.org/works/10.1210%2FER.2004-0002

7 January 2021

A vitamin D analog, MC1288, inhibits adventitial inflammation and suppresses intimal lesions in rat aortic allografts

1 reference

https://api.crossref.org/works/10.1210%2FER.2004-0002

7 January 2021

Prolongation of allograft survival by 1,25-dihydroxyvitamin D3.

1 reference

https://api.crossref.org/works/10.1210%2FER.2004-0002

7 January 2021

Reduction of immunosuppressant therapy requirement in heart transplantation by calcitriol

1 reference

https://api.crossref.org/works/10.1210%2FER.2004-0002

7 January 2021

Transcriptional activation of the Cdk inhibitor p21 by vitamin D3 leads to the induced differentiation of the myelomonocytic cell line U937.

1 reference

https://api.crossref.org/works/10.1210%2FER.2004-0002

7 January 2021

Human TAF(II)135 potentiates transcriptional activation by the AF-2s of the retinoic acid, vitamin D3, and thyroid hormone receptors in mammalian cells

1 reference

https://api.crossref.org/works/10.1210%2FER.2004-0002

7 January 2021

A novel protein complex that interacts with the vitamin D3 receptor in a ligand-dependent manner and enhances VDR transactivation in a cell-free system

1 reference

https://api.crossref.org/works/10.1210%2FER.2004-0002

7 January 2021

Growth-inhibitory effects of 1,25-dihydroxyvitamin D3 on normal and psoriatic keratinocytes

1 reference

https://api.crossref.org/works/10.1210%2FER.2004-0002

7 January 2021

1α,25‐Dihydroxyvitamin D3 and a Variety of its Natural Metabolites Transcriptionally Repress Nuclear‐Factor‐κB‐Mediated Interleukin‐8 Gene Expression

1 reference

https://api.crossref.org/works/10.1210%2FER.2004-0002

7 January 2021

Calcipotriol: a new drug for topical psoriasis treatment

1 reference

https://api.crossref.org/works/10.1210%2FER.2004-0002

7 January 2021

Vitamin D receptor as an intestinal bile acid sensor

1 reference

https://api.crossref.org/works/10.1210%2FER.2004-0002

7 January 2021

Sequence and characterization of a coactivator for the steroid hormone receptor superfamily

1 reference

https://api.crossref.org/works/10.1210%2FER.2004-0002

7 January 2021

Inhibitory function of p21Cip1/WAF1 in differentiation of primary mouse keratinocytes independent of cell cycle control

1 reference

https://api.crossref.org/works/10.1210%2FER.2004-0002

7 January 2021

1,25-Dihydroxyvitamin D3Receptors in Human Leukocytes

1 reference

https://api.crossref.org/works/10.1210%2FER.2004-0002

7 January 2021

1,25-dihydroxyvitamin D3: a novel immunoregulatory hormone

1 reference

https://api.crossref.org/works/10.1210%2FER.2004-0002

7 January 2021

Ligand modulates the conversion of DNA-bound vitamin D3 receptor (VDR) homodimers into VDR-retinoid X receptor heterodimers

1 reference

https://api.crossref.org/works/10.1210%2FER.2004-0002

7 January 2021

Transcriptional repression of the interleukin-2 gene by vitamin D3: direct inhibition of NFATp/AP-1 complex formation by a nuclear hormone receptor

1 reference

https://api.crossref.org/works/10.1210%2FER.2004-0002

7 January 2021

GRIP1, a transcriptional coactivator for the AF-2 transactivation domain of steroid, thyroid, retinoid, and vitamin D receptors

1 reference

https://api.crossref.org/works/10.1210%2FER.2004-0002

7 January 2021

A Differential Screen for Ligand-Regulated Genes: Identification of HoxA10 as a Target of Vitamin D3 Induction in Myeloid Leukemic Cells

1 reference

https://api.crossref.org/works/10.1210%2FER.2004-0002

7 January 2021

Human TAF(II)55 interacts with the vitamin D(3) and thyroid hormone receptors and with derivatives of the retinoid X receptor that have altered transactivation properties

1 reference

https://api.crossref.org/works/10.1210%2FER.2004-0002

7 January 2021

The DRIP complex and SRC-1/p160 coactivators share similar nuclear receptor binding determinants but constitute functionally distinct complexes

1 reference

https://api.crossref.org/works/10.1210%2FER.2004-0002

7 January 2021

Determinants of CoRNR-dependent repression complex assembly on nuclear hormone receptors

1 reference

https://api.crossref.org/works/10.1210%2FER.2004-0002

7 January 2021

Calcipotriol inhibits rectal epithelial cell proliferation in ulcerative proctocolitis

1 reference

https://api.crossref.org/works/10.1210%2FER.2004-0002

7 January 2021

Immunobiology of dendritic cells

1 reference

https://api.crossref.org/works/10.1210%2FER.2004-0002

7 January 2021

Vitamin D analogs for the treatment of secondary hyperparathyroidism

1 reference

https://api.crossref.org/works/10.1210%2FER.2004-0002

7 January 2021

A new calcipotriol/betamethasone dipropionate formulation (Daivobet) is an effective once-daily treatment for psoriasis vulgaris

1 reference

https://api.crossref.org/works/10.1210%2FER.2004-0002

7 January 2021

Long-term use of topical calcipotriol in chronic plaque psoriasis.

1 reference

https://api.crossref.org/works/10.1210%2FER.2004-0002

7 January 2021

1 alpha,25-dihydroxyvitamin D(3) inhibits angiogenesis in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1210%2FER.2004-0002

7 January 2021

1,25-Dihydroxyvitamin D(3) is a negative endocrine regulator of the renin-angiotensin system

1 reference

https://api.crossref.org/works/10.1210%2FER.2004-0002

7 January 2021

Inhibition of IL-12 production by 1,25-dihydroxyvitamin D3. Involvement of NF-kappaB downregulation in transcriptional repression of the p40 gene.

1 reference

https://api.crossref.org/works/10.1210%2FER.2004-0002

7 January 2021

Inhibition of T lymphocyte mitogenesis by 1,25-dihydroxyvitamin D3 (calcitriol)

1 reference

https://api.crossref.org/works/10.1210%2FER.2004-0002

7 January 2021

Regulation of lymphokine production and human T lymphocyte activation by 1,25-dihydroxyvitamin D3. Specific inhibition at the level of messenger RNA

1 reference

https://api.crossref.org/works/10.1210%2FER.2004-0002

7 January 2021

Granulocyte-macrophage colony-stimulating factor. Sensitive and receptor-mediated regulation by 1,25-dihydroxyvitamin D3 in normal human peripheral blood lymphocytes

1 reference

https://api.crossref.org/works/10.1210%2FER.2004-0002

7 January 2021

Regulation of parathyroid hormone-like peptide in cultured normal human keratinocytes. Effect of growth factors and 1,25 dihydroxyvitamin D3 on gene expression and secretion

1 reference

https://api.crossref.org/works/10.1210%2FER.2004-0002

7 January 2021

Metabolic and cellular analysis of alopecia in vitamin D receptor knockout mice

1 reference

https://api.crossref.org/works/10.1210%2FER.2004-0002

7 January 2021

Current experience with tacalcitol ointment in the treatment of psoriasis

1 reference

https://api.crossref.org/works/10.1210%2FER.2004-0002

7 January 2021

The effects of 1 alpha,25-dihydroxyvitamin D(3) on matrix metalloproteinase and prostaglandin E(2) production by cells of the rheumatoid lesion

1 reference

https://api.crossref.org/works/10.1210%2FER.2004-0002

7 January 2021

Weekly high-dose calcitriol and docetaxel in metastatic androgen-independent prostate cancer

1 reference

https://api.crossref.org/works/10.1210%2FER.2004-0002

7 January 2021

Modulation of osteoclast differentiation and function by the new members of the tumor necrosis factor receptor and ligand families

1 reference

https://api.crossref.org/works/10.1210%2FER.2004-0002

7 January 2021

Inhibition of spontaneous and androgen-induced prostate growth by a nonhypercalcemic calcitriol analog

1 reference

https://api.crossref.org/works/10.1210%2FER.2004-0002

7 January 2021

Suppression by 1,25(OH)2D3 of transcription of the pre-proparathyroid hormone gene

1 reference

https://api.crossref.org/works/10.1210%2FER.2004-0002

7 January 2021

Vitamin D and prostate cancer: 1,25 dihydroxyvitamin D3 receptors and actions in human prostate cancer cell lines

1 reference

https://api.crossref.org/works/10.1210%2FER.2004-0002

7 January 2021

Prevention of type I diabetes in NOD mice by nonhypercalcemic doses of a new structural analog of 1,25-dihydroxyvitamin D3, KH1060

1 reference

https://api.crossref.org/works/10.1210%2FER.2004-0002

7 January 2021

Vitamin D-mediated gene regulation in phenotypically defined human B cell subpopulations

1 reference

https://api.crossref.org/works/10.1210%2FER.2004-0002

7 January 2021

Aberrant growth plate development in VDR/RXR gamma double null mutant mice.

1 reference

https://api.crossref.org/works/10.1210%2FER.2004-0002

7 January 2021

Targeting expression of the human vitamin D receptor to the keratinocytes of vitamin D receptor null mice prevents alopecia

1 reference

https://api.crossref.org/works/10.1210%2FER.2004-0002

7 January 2021

Cellular and molecular events associated with the bone-protecting activity of the noncalcemic vitamin D analog Ro-26-9228 in osteopenic rats

1 reference

https://api.crossref.org/works/10.1210%2FER.2004-0002

7 January 2021

Demonstration of 1,25-dihydroxyvitamin D3 receptors in human skin biopsies

1 reference

https://api.crossref.org/works/10.1210%2FER.2004-0002

7 January 2021

Vitamin D: more than a "bone-a-fide" hormone.

1 reference

https://api.crossref.org/works/10.1210%2FER.2004-0002

7 January 2021

Identification of a functional vitamin D response element in the human insulin-like growth factor binding protein-3 promoter

1 reference

https://api.crossref.org/works/10.1210%2FER.2004-0002

7 January 2021

Evidence for Ligand-Dependent Intramolecular Folding of the AF-2 Domain in Vitamin D Receptor-Activated Transcription and Coactivator Interaction

1 reference

https://api.crossref.org/works/10.1210%2FER.2004-0002

7 January 2021

The nuclear receptor corepressor (N-CoR) contains three isoleucine motifs (I/LXXII) that serve as receptor interaction domains (IDs).

1 reference

https://api.crossref.org/works/10.1210%2FER.2004-0002

7 January 2021

Antiproliferative effects of 1,25-dihydroxyvitamin D3 on breast cells: a mini review

1 reference

https://api.crossref.org/works/10.1210%2FER.2004-0002

7 January 2021

Inhibition of proliferation of prostate cancer cells by a 19-nor-hexafluoride vitamin D3 analogue involves the induction of p21waf1, p27kip1 and E-cadherin

1 reference

https://api.crossref.org/works/10.1210%2FER.2004-0002

7 January 2021

Growth inhibition of both MCF-7 and Hs578T human breast cancer cell lines by vitamin D analogues is associated with increased expression of insulin-like growth factor binding protein-3

1 reference

https://api.crossref.org/works/10.1210%2FER.2004-0002

7 January 2021

Antisense knockout of HOXB4 blocks 1,25-dihydroxyvitamin D3 inhibition of c-myc expression

1 reference

https://api.crossref.org/works/10.1210%2FER.2004-0002

7 January 2021

Vitamin D analogs: mechanism of action and therapeutic applications

1 reference

https://api.crossref.org/works/10.1210%2FER.2004-0002

7 January 2021

Recent developments in vitamin D analogs

1 reference

https://api.crossref.org/works/10.1210%2FER.2004-0002

7 January 2021

Vitamin D receptor as a drug discovery target

1 reference

https://api.crossref.org/works/10.1210%2FER.2004-0002

7 January 2021

The vitamin D3 analog EB 1089 enhances the response of human breast tumor cells to radiation.

1 reference

https://api.crossref.org/works/10.1210%2FER.2004-0002

7 January 2021

1alpha,25-dihydroxyvitamin D3 induces an autoantigen-specific T-helper 1/T-helper 2 immune shift in NOD mice immunized with GAD65 (p524-543)

1 reference

https://api.crossref.org/works/10.1210%2FER.2004-0002

7 January 2021

A 1alpha,25-dihydroxyvitamin D(3) analog enhances regulatory T-cells and arrests autoimmune diabetes in NOD mice

1 reference

https://api.crossref.org/works/10.1210%2FER.2004-0002

7 January 2021

Low serum vitamin D metabolites in women with rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1210%2FER.2004-0002

7 January 2021

1,25-Dihydroxyvitamin D3 attenuates the expression of experimental murine lupus of MRL/l mice

1 reference

https://api.crossref.org/works/10.1210%2FER.2004-0002

7 January 2021

Prevention of immunological disorders in MRL/l mice by a new synthetic analogue of vitamin D3: 22-oxa-1 alpha,25-dihydroxyvitamin D3

1 reference

https://api.crossref.org/works/10.1210%2FER.2004-0002

7 January 2021

Vitamin D and Multiple Sclerosis

1 reference

https://api.crossref.org/works/10.1210%2FER.2004-0002

7 January 2021

The current state of hormonal therapy for prostate cancer

1 reference

https://api.crossref.org/works/10.1210%2FER.2004-0002

7 January 2021

1 Alpha,25-dihydroxyvitamin D3 inhibits differentiation, maturation, activation, and survival of dendritic cells leading to impaired alloreactive T cell activation

1 reference

https://api.crossref.org/works/10.1210%2FER.2004-0002

7 January 2021

Vitamin D3 affects differentiation, maturation, and function of human monocyte-derived dendritic cells

1 reference

https://api.crossref.org/works/10.1210%2FER.2004-0002

7 January 2021

1alpha,25-Dihydroxyvitamin d3 has a direct effect on naive CD4(+) T cells to enhance the development of Th2 cells.

1 reference

https://api.crossref.org/works/10.1210%2FER.2004-0002

7 January 2021

Treatment of postmenopausal osteoporosis with high doses of synthetic calcitriol. A randomized controlled study

1 reference

https://api.crossref.org/works/10.1210%2FER.2004-0002

7 January 2021